Pulmonary complications of solid organ and hematopoietic stem cell transplantation
RM Kotloff, VN Ahya, SW Crawford - American journal of respiratory …, 2004 - atsjournals.org
The ability to successfully transplant solid organs and hematopoietic stem cells represents
one of the landmark medical achievements of the twentieth century. Solid organ …
one of the landmark medical achievements of the twentieth century. Solid organ …
Cytomegalovirus
PD Griffiths - Principles and practice of clinical virology, 1999 - Wiley Online Library
Cytomegalovirus (CMV) infections were first described in the early years of the twentieth
century when the typical owl's eye intranuclear inclusions were found by histopathologists in …
century when the typical owl's eye intranuclear inclusions were found by histopathologists in …
Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients
AC Kalil, J Levitsky, E Lyden, J Stoner… - Annals of internal …, 2005 - acpjournals.org
Background: Cytomegalovirus (CMV), the most common opportunistic viral infection in solid
organ transplant recipients, is associated with substantial morbidity and mortality. Purpose …
organ transplant recipients, is associated with substantial morbidity and mortality. Purpose …
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
UP Neumann, T Berg, M Bahra, D Seehofer… - Journal of …, 2004 - Elsevier
BACKGROUND/AIMS: Aim of our study was to analyze fibrosis progression after liver
transplantation (OLT) in hepatitis C virus (HCV)-infected patients based on protocol liver …
transplantation (OLT) in hepatitis C virus (HCV)-infected patients based on protocol liver …
[HTML][HTML] Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients
Though an important cause of morbidity and mortality in solid organ transplantation (SOT),
the long-term outcomes of cytomegalovirus (CMV) disease treatment have not been well …
the long-term outcomes of cytomegalovirus (CMV) disease treatment have not been well …
Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies
LN Small, J Lau, DR Snydman - Clinical infectious diseases, 2006 - academic.oup.com
Background. Cytomegalovirus (CMV) causes significant morbidity and mortality in transplant
recipients, but there is no consensus regarding the most appropriate prevention method …
recipients, but there is no consensus regarding the most appropriate prevention method …
Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
DS Owers, AC Webster, GFM Strippoli… - Cochrane database …, 2013 - cochranelibrary.com
Background Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in solid
organ transplant recipients. Pre‐emptive treatment of patients with CMV viraemia using …
organ transplant recipients. Pre‐emptive treatment of patients with CMV viraemia using …
A direct and indirect comparison meta-analysis on the efficacy of cytomegalovirus preventive strategies in solid organ transplant
DF Florescu, F Qiu, CM Schmidt… - Clinical infectious …, 2014 - academic.oup.com
Background. Prophylactic and preemptive strategies are used to prevent cytomegalovirus
(CMV) infections after solid organ transplant. We assessed the safety and efficacy of both …
(CMV) infections after solid organ transplant. We assessed the safety and efficacy of both …
[PDF][PDF] Diarrhea in liver transplant recipients: etiology and management
PM Ginsburg, PJ Thuluvath - Liver Transplantation, 2005 - Wiley Online Library
Diarrhea is common after liver transplantation (LT). The true incidence of diarrhea in liver
transplant recipients is unknown but possibly ranges from 10% to 43% based on a few …
transplant recipients is unknown but possibly ranges from 10% to 43% based on a few …
[HTML][HTML] Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients
An effective host immune response, critical for successful control of Cytomegalovirus (CMV)
disease in solid organ transplant recipients, is affected by intensity and type of …
disease in solid organ transplant recipients, is affected by intensity and type of …